17.34
2.20%
-0.39
After Hours:
17.405
0.065
+0.37%
Overview
News
Price History
Option Chain
Why WBA Down?
Discussions
Forecast
Stock Split
Dividend History
Walgreens Boots Alliance Inc stock is currently priced at $17.34, with a 24-hour trading volume of 10.76M.
It has seen a -2.20% decreased in the last 24 hours and a -11.26% declined in the past month.
The chart indicates a potential bearish trend, as the stock is below the $17.71 pivot point. If it approaches the $17.30 support level, significant changes may occur.
Previous Close:
$17.73
Open:
$17.414
24h Volume:
10.76M
Market Cap:
$14.96B
Revenue:
$144.60B
Net Income/Loss:
$-6.04B
P/E Ratio:
-4.8571
EPS:
-3.57
Net Cash Flow:
$-1.77B
1W Performance:
-2.64%
1M Performance:
-11.26%
6M Performance:
-15.95%
1Y Performance:
-49.90%
Walgreens Boots Alliance Inc Stock (WBA) Company Profile
Name
Walgreens Boots Alliance Inc
Sector
Industry
Phone
847-315-2500
Address
108 Wilmot Road, Deerfield, IL
Walgreens Boots Alliance Inc Stock (WBA) Upgrades & Downgrades
Date | Action | Analyst | Rating Change |
---|---|---|---|
Jan-03-24 | Initiated | Barclays | Underweight |
Dec-22-23 | Initiated | HSBC Securities | Hold |
Oct-23-23 | Upgrade | JP Morgan | Neutral → Overweight |
Jul-03-23 | Reiterated | Morgan Stanley | Underweight |
Jun-28-23 | Downgrade | Deutsche Bank | Buy → Hold |
Feb-23-23 | Initiated | Loop Capital | Buy |
Nov-23-22 | Resumed | Morgan Stanley | Underweight |
Nov-22-22 | Upgrade | Cowen | Market Perform → Outperform |
Nov-18-22 | Upgrade | JP Morgan | Neutral → Overweight |
Nov-11-22 | Upgrade | Deutsche Bank | Hold → Buy |
Apr-01-22 | Downgrade | Robert W. Baird | Outperform → Neutral |
Dec-16-21 | Downgrade | Morgan Stanley | Equal-Weight → Underweight |
Mar-25-21 | Reiterated | Deutsche Bank | Hold |
Jan-11-21 | Upgrade | Guggenheim | Neutral → Buy |
Jan-11-21 | Upgrade | Robert W. Baird | Neutral → Outperform |
Jan-08-21 | Resumed | Credit Suisse | Neutral |
Apr-06-20 | Upgrade | UBS | Sell → Neutral |
Apr-03-20 | Upgrade | Deutsche Bank | Sell → Hold |
Dec-11-19 | Downgrade | Wells Fargo | Outperform → Market Perform |
Oct-30-19 | Reiterated | Pivotal Research Group | Hold |
Oct-23-19 | Downgrade | JP Morgan | Overweight → Neutral |
Sep-27-19 | Resumed | RBC Capital Mkts | Sector Perform |
Sep-12-19 | Initiated | Deutsche Bank | Sell |
Apr-18-19 | Initiated | Guggenheim | Neutral |
Apr-03-19 | Downgrade | Loop Capital | Buy → Hold |
Apr-03-19 | Reiterated | Pivotal Research Group | Hold |
Mar-08-19 | Reiterated | BofA/Merrill | Underperform |
Jan-17-19 | Initiated | UBS | Sell |
Dec-19-18 | Resumed | Wolfe Research | Peer Perform |
Dec-14-18 | Downgrade | Goldman | Neutral → Sell |
Oct-15-18 | Reiterated | Pivotal Research Group | Hold |
Oct-08-18 | Reiterated | RBC Capital Mkts | Outperform |
Jul-10-18 | Downgrade | Evercore ISI | Outperform → In-line |
Jul-09-18 | Downgrade | Citigroup | Buy → Neutral |
Jul-02-18 | Reiterated | Pivotal Research Group | Hold |
Jun-29-18 | Downgrade | Robert W. Baird | Outperform → Neutral |
View All
Walgreens Boots Alliance Inc Stock (WBA) Latest News
Walgreens Boots Alliance, Inc. (WBA) Is a Trending Stock: Facts to Know Before Betting on It
Zacks Investment Research
History Says the Nasdaq Could Soar: 2 Top Growth Stocks to Buy Now and Hold for the Bull Market
The Motley Fool
SCHD: If You've Won The Game, Take A Little Off The Top
Seeking Alpha
Beat the Dow Jones With This Cash-Gushing Dividend Stock
The Motley Fool
Walgreens Boots Alliance, Inc. (WBA) Is a Trending Stock: Facts to Know Before Betting on It
Zacks Investment Research
Insiders Buying Walgreens And 2 Other Stocks
Benzinga
Walgreens Boots Alliance Inc Stock (WBA) Financials Data
Walgreens Boots Alliance Inc (WBA) Revenue 2024
WBA reported a revenue (TTM) of $144.60 billion for the quarter ending February 29, 2024, a +8.48% rise year-over-year.
Walgreens Boots Alliance Inc (WBA) Net Income 2024
WBA net income (TTM) was -$6.04 billion for the quarter ending February 29, 2024, a -92.02% decrease year-over-year.
Walgreens Boots Alliance Inc (WBA) Cash Flow 2024
WBA recorded a free cash flow (TTM) of -$1.77 billion for the quarter ending February 29, 2024, a -279.84% decrease year-over-year.
Walgreens Boots Alliance Inc (WBA) Earnings per Share 2024
WBA earnings per share (TTM) was -$7.00 for the quarter ending February 29, 2024, a -91.78% decline year-over-year.
Walgreens Boots Alliance Inc Stock (WBA) Insider Trading
Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
---|---|---|---|---|---|---|---|
Mahajan Manmohan | EVP and Global CFO |
Apr 02 '24 |
Buy |
19.38 |
6,000 |
116,280 |
166,969 |
Walgreens Boots Alliance, Inc. | 10% Owner |
Feb 07 '24 |
Sale |
235.41 |
4,212,395 |
991,639,907 |
26,277,561 |
JARRETT VALERIE B | Director |
Jan 29 '24 |
Buy |
22.44 |
4,456 |
99,993 |
4,456 |
SCHLICHTING NANCY M | Director |
Jan 16 '24 |
Sale |
23.05 |
15,209 |
350,567 |
0 |
WENTWORTH TIMOTHY C | Chief Executive Officer |
Jan 05 '24 |
Buy |
24.22 |
10,000 |
242,220 |
585,122 |
Gates Richard P. | SVP, Chief Pharmacy Officer |
Nov 10 '23 |
Sale |
20.45 |
1,000 |
20,450 |
73,929 |
Walgreens Boots Alliance, Inc. | 10% Owner |
Nov 09 '23 |
Sale |
195.38 |
1,279,590 |
249,999,896 |
30,489,956 |
Walgreens Boots Alliance, Inc. | 10% Owner |
Aug 03 '23 |
Sale |
189.27 |
1,320,858 |
250,000,115 |
31,769,546 |
DRISCOLL JOHN PATRICK | EVP, Pres. U.S. Healthcare |
Jun 30 '23 |
Buy |
28.42 |
5,172 |
146,984 |
59,050 |
Walgreens Boots Alliance, Inc. | 10% Owner |
Jun 15 '23 |
Sale |
181.17 |
275,984 |
50,000,021 |
33,090,404 |
About Walgreens Boots Alliance Inc
Walgreens Boots Alliance, Inc. operates as a pharmacy-led health and wellbeing company. It operates through three segments: Retail Pharmacy USA, Retail Pharmacy International, and Pharmaceutical Wholesale. The Retail Pharmacy USA segment sells prescription drugs and an assortment of retail products, including health, beauty, personal care, consumable, and general merchandise products through its retail drugstores and convenient care clinics. It also provides specialty pharmacy services and mail services; and manages in-store clinics. As of August 31, 2018, this segment operated 9,560 retail stores under the Walgreens and Duane Reade brands in the United States; and 7 specialty pharmacies, as well as approximately 400 in-store clinic locations. The Retail Pharmacy International segment sells prescription drugs; and health, beauty, personal care, and other consumer products through its pharmacy-led health and beauty stores and optical practices, as well as through boots.com and an integrated mobile application. This segment operated 4,767 retail stores under the Boots, Benavides, and Ahumada in the United Kingdom, Thailand, Norway, the Republic of Ireland, the Netherlands, Mexico, and Chile; and 618 optical practices, including 167 on a franchise basis. The Pharmaceutical Wholesale segment engages in the wholesale and distribution of specialty and generic pharmaceuticals, health and beauty products, and home healthcare supplies and equipment, as well as provides related services to pharmacies and other healthcare providers. This segment operates in the United Kingdom, Germany, France, Turkey, Spain, the Netherlands, Egypt, Norway, Romania, the Czech Republic, and Lithuania. Walgreens Boots Alliance, Inc. was founded in 1901 and is based in Deerfield, Illinois.
Cap:
|
Volume (24h):